SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS

by I. V. Dmytrenko, Zh. M Minchenko, V. V. Fedorenko, I. S. Dyagil
Published 2019-07-01

Calculations of supramolecular structures of peptidylboronic acid (bortezomib) with ABO blood system antigen

by A. D. Kustovska, S. V. Prymachenko, Zh. M. Minchenko, T. F. Liubarets, O. O. Dmytrenko
Published 2019-08-01

The role of exosomes in the mechanisms of inflammation development in patients with cardiovascular pathology and the contribution to therapeutic potential of stem cells

by P. F. Muzychenko, Zh. M. Minchenko, T. I. Havrylenko, V. A. Cherniak, S. V. Demidov, N. O. Ryzhkova, O. A. Pidhaina
Published 2021-07-01